Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01593228
Title Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi

Advanced Solid Tumor


Carboplatin + Doxorubicin + Iniparib

Iniparib + Paclitaxel

Iniparib + Irinotecan

Iniparib + Topotecan

Carboplatin + Gemcitabine + Iniparib


Age Groups: adult
Covered Countries USA | ITA | ESP | BEL

No variant requirements are available.